Global X Genomics & Biotechnology ETF (NYSE: GNOM) — Perfil da empresa, notícias e dados financeiros
Global X Genomics & Biotechnology ETF offers exposure to gene editing and biotechnological innovation.
Global X Genomics & Biotechnology ETF
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) focuses on investment opportunities within the genomics and biotechnology sector, aiming to provide investors with exposure to companies involved in gene editing, genomic sequencing, and biotechnological innovation. This ETF selects companies at the forefront of genetic engineering, diagnostic solutions, and personalized medicine, aiming to capitalize on the rapid advancements in these areas. Its objective is to offer long-term capital growth by tracking the performance of the Solactive Genomics Index, which encompasses firms globally that stand to potentially benefit from further advances and applications in the field of genomics. By investing in Global X Genomics & Biotechnology ETF, investors get exposure to a cutting-edge sector that is poised to revolutionize healthcare, agriculture, and pharmaceuticals among other industries.
Resumo
Operações
Produtos e/ou serviços de Global X Genomics & Biotechnology ETF
- Invests in companies involved in genomics and biotechnology, aiming to benefit from advances in genetic engineering and diagnostics.
- Focuses on firms developing treatments for rare genetic diseases, aiming to improve patient outcomes and quality of life.
- Supports companies engaging in CRISPR technology for precise DNA editing, fostering innovations in disease treatment.
- Backs businesses in personalized medicine, utilizing genetic information to tailor treatments to individual genetic profiles.
- Invests in agricultural biotechnology companies improving crop yield and resistance, contributing to food security.
- Promotes investments in companies advancing reproductive genetics, enhancing fertility treatments and genetic screening.